At Dada Laser Eye Institute (DLEI), we provide advanced intravitreal anti-VEGF treatment for Retinal diseases including:
- Diabetic Retinopathy
- Wet Age-Related Macular Degeneration (AMD)
- Retinal Vein Occlusions
- Myopic Macular Degeneration
How Anti-VEGF Therapy Works
This Therapy is administered by injecting a specific drug—usually Ranibizumab, Aflibercept, or Bevacizumab—straight into the vitreous space of the eye. Under aseptic conditions, the drug prevents the action of VEGF by binding to it. This has the following effects:
- Less leakage of liquid into the Retina
- Shrinkage of Pathological blood vessels
- Avoidance or slowing of vision deterioration
Advantages of Anti-VEGF Therapy
- Slows disease progression significantly
- Can enhance visual acuity in most instances
- Minimally Invasive and conducted under topical Anesthesia
- Secure and comfortable in DLEI’s state-of-the-art operation rooms
Treatment plans for each patient are tailored, frequently requiring several sessions depending on how they react. Our Retina experts combine advanced diagnostic equipment such as OCT imaging with experienced surveillance in order to achieve the optimal visual results.
DLEI is committed to restoring and maintaining your vision with the newest anti-VEGF treatments, administered with empathy and clinical distinction.
